page 11 - Patient 21

PATIENT 21

The right to health: access to healthcare

VIDEO Diabetes: A Developing Disease

Innovation: a priority

PRIMARY PARTNERSHIPS AND ACQUISITIONS

Information and patient education

FOCUS “Comida Que Cuida”

Pharmacovigilance: a safety imperative

FOCUS An ambitious drug-monitoring program for ASAQ in Africa

The fight against counterfeit drugs: a public health challenge

PARTNERSHIP The Cotonou Declaration

The patient at the center of the Group’s commitments

Sanofi-aventis upholds its commitment to health and prevention by acting in an ethical and responsible manner. This commitment is built on a social contract between patients and the Group. Respecting this contract requires careful consideration of healthcare needs and expectations; it necessitates placing the patient at the center of our business strategy. The Group’s commitment takes shape in programs that promote access to healthcare, for both medicines and vaccines. There are many ways to be attentive to needs: paying greater attention to neglected tropical diseases, transforming our approach to Research and Development (R&D), and seeking innovation in sanofi-aventis’ relationship with patients. Ultimately, it means being ever more vigilant about product quality, safety and the services we provide to patients. Sanofi-aventis upholds its commitment to health and prevention by acting in an
ethical and responsible manner. This commitment is built on a social contract
between patients and the Group. Respecting this contract requires careful
consideration of healthcare needs and expectations; it necessitates placing
the patient at the center of our business strategy. The Group’s commitment
takes shape in programs that promote access to healthcare, for both medicines
and vaccines. There are many ways to be attentive to needs: paying greater
attention to neglected tropical diseases, transforming our approach to
Research and Development (R&D), and seeking innovation in sanofi-aventis’
relationship with patients. Ultimately, it means being ever more vigilant
about product quality, safety and the services we provide to patients.